SEC Form 4 · accession 0001425450-26-000085
ORTHOPEDIATRICS CORP · KIDS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David R Pelizzon
Director · 10% Owner
Period of report
Sep 2, 2026
Accepted (ET)
Sep 4, 2026 · 4:26 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001425450
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Sep 2, 2026 | S | 22,500 | $23.35 | D | 6,504,133 | I | See footnote |
| Common StockF4 | holding | — | — | — | 44,384 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.01 to $23.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F3These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.
- F4Includes restricted stock awards totaling 17,959 shares.